Inventor · disambiguated record
Marie-Ange Buyse
Also filed as: BUYSE MARIE-ANGE
57 granted patents·31 pending applications·475 citations·filing 1995–2025
99Inventor score
Files withABLYNX NV36INNOGENETICS NV12BOEHRINGER INGELHEIM INT11MERCK SHARP & DOHME6NOVO NORDISK AS4
Top patents by PatentIndex Score
88 records- 0199US11485777B2Immunoglobulin variable domainsABLYNX NV·Filed 2021·Granted Nov 1, 2022·8 cites·16 claims
- 0299US11485778B2Immunoglobulin variable domainsABLYNX NV·Filed 2021·Granted Nov 1, 2022·7 cites·10 claims
- 0399US11319364B2Immunoglobulin variable domainsABLYNX NV·Filed 2021·Granted May 3, 2022·8 cites·13 claims
- 0499US11312765B2Immunoglobulin variable domainsABLYNX NV·Filed 2021·Granted Apr 26, 2022·9 cites·15 claims
- 0599US11220539B2Immunoglobulin variable domainsABLYNX NV·Filed 2020·Granted Jan 11, 2022·9 cites·23 claims
- 0698US11708404B2Immunoglobulin variable domainsABLYNX NV·Filed 2022·Granted Jul 25, 2023·4 cites·14 claims
- 0797US11753465B2Nucleic acids encoding polypeptides against IL-23ABLYNX NV·Filed 2021·Granted Sep 12, 2023·3 cites·12 claims
- 0897US11312764B2Immunoglobulin variable domainsABLYNX NV·Filed 2019·Granted Apr 26, 2022·10 cites·19 claims
- 0997US10858418B2Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domainsABLYNX NV·Filed 2020·Granted Dec 8, 2020·18 cites·20 claims
- 1096US10323090B2PD1 and/or LAG3 bindersMERCK SHARP & DOHME·Filed 2016·Granted Jun 18, 2019·26 cites·31 claims
- 1195US11142569B2Serum albumin-binding immunoglobulin variable domainsABLYNX NV·Filed 2016·Granted Oct 12, 2021·10 cites·11 claims
- 1295US10968271B2Polypeptides against IL-23ABLYNX NV·Filed 2016·Granted Apr 6, 2021·9 cites·8 claims
- 1394US9745372B2TNF bindersABLYNX NV·Filed 2017·Granted Aug 29, 2017·18 cites·2 claims
- 1493US11332519B2Serum albumin bindersABLYNX NV·Filed 2016·Granted May 17, 2022·7 cites·18 claims
- 1593US11009511B2Methods for detecting and/or measuring anti-drug antibodies, in particular treatment-emergent anti-drug antibodiesABLYNX NV·Filed 2015·Granted May 18, 2021·6 cites·7 claims
- 1693US10544222B2PD1/CTLA4 bindersMERCK SHARP & DOHME·Filed 2016·Granted Jan 28, 2020·22 cites·15 claims
- 1793US10501542B2CTLA4 bindersMERCK SHARP & DOHME·Filed 2016·Granted Dec 10, 2019·16 cites·15 claims
- 1892US11192937B2Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domainsABLYNX NV·Filed 2017·Granted Dec 7, 2021·5 cites·6 claims
- 1992US11192938B2Serum albumin binding proteins containing immunoglobulin single variable domainsABLYNX NV·Filed 2017·Granted Dec 7, 2021·5 cites·35 claims
- 2092US10544211B2TNF bindersABLYNX NV·Filed 2016·Granted Jan 28, 2020·14 cites·4 claims
- 2191US11155619B2PD1 and/or LAG3 bindersMERCK SHARP & DOHME·Filed 2019·Granted Oct 26, 2021·4 cites·8 claims
- 2290US11161916B2Bispecific binding molecules binding to VEGF and Ang2BOEHRINGER INGELHEIM INT·Filed 2019·Granted Nov 2, 2021·4 cites·5 claims
- 2389US11952418B2Biparatopic polypeptides antagonizing Wnt signaling in tumor cellsBOEHRINGER INGELHEIM INT·Filed 2020·Granted Apr 9, 2024·2 cites·3 claims
- 2489US11261260B2ADAMTS binding immunoglobulinsMERCK PATENT GMBH·Filed 2018·Granted Mar 1, 2022·4 cites·30 claims
- 2588US12180268B2Immunoglobulin variable domainsABLYNX NV·Filed 2015·Granted Dec 31, 2024·2 cites·10 claims
- 2687US11168136B2PD1 and/or LAG3 bindersMERCK SHARP & DOHME·Filed 2019·Granted Nov 9, 2021·2 cites·18 claims
- 2787US11168135B2PD1 and/or LAG3 bindersMERCK SHARP & DOHME·Filed 2019·Granted Nov 9, 2021·2 cites·16 claims
- 2887US9527925B2Bispecific binding molecules binding to VEGF and ANG2GSCHWIND ANDREAS·Filed 2012·Granted Dec 27, 2016·16 cites·24 claims
- 2987US9328174B2Chemokine receptor binding polypeptidesNOVARTIS AG·Filed 2013·Granted May 3, 2016·8 cites·11 claims
- 3087US6350860B1Interferon-gamma-binding molecules for treating septic shock, cachexia, immune diseases and skin disordersINNOGENETICS NV·Filed 1998·Granted Feb 26, 2002·68 cites·14 claims
- 3186US8969542B2HPV polyepitope constructs and uses thereofBUYSE MARIE-ANGE·Filed 2008·Granted Mar 3, 2015·12 cites·13 claims
- 3285US12006352B2Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domainsABLYNX NV·Filed 2020·Granted Jun 11, 2024·1 cites·6 claims
- 3385US11787874B2Factor X binders enhancing FX activationNOVO NORDISK AS·Filed 2018·Granted Oct 17, 2023·3 cites·7 claims
- 3485US6150134APurified hepatitis C virus envelope proteins for diagnostic and therapeutic useINNOGENETICS NV·Filed 1995·Granted Nov 21, 2000·43 cites·26 claims
- 3585US2023242620A1Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domainsABLYNX NV·Filed 2023·Application pending·0 cites
- 3684US10414828B2Bispecific binding molecules binding to VEGF and Ang2BOEHRINGER INGELHEIM INT·Filed 2016·Granted Sep 17, 2019·4 cites·13 claims
- 3783US11306139B2Glycosylated immunoglobulin single variable domainsABLYNX NV·Filed 2016·Granted Apr 19, 2022·2 cites·24 claims
- 3883US11033636B2Polypeptides antagonizing Wnt signaling in tumor cellsBOEHRINGER INGELHEIM INT·Filed 2018·Granted Jun 15, 2021·2 cites·9 claims
- 3983US2022332806A1Immunoglobulin variable domainsABLYNX NV·Filed 2022·Application pending·0 cites
- 4083US2022332807A1Immunoglobulin variable domainsABLYNX NV·Filed 2022·Application pending·0 cites
- 4182US10597449B2Biparatopic polypeptides antagonizing Wnt signaling in tumor cellsBOEHRINGER INGELHEIM INT·Filed 2016·Granted Mar 24, 2020·4 cites·13 claims
- 4282US2023203146A1Ang2-binding moleculesBOEHRINGER INGELHEIM INT·Filed 2023·Application pending·0 cites
- 4381US11644471B2Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domainsABLYNX NV·Filed 2013·Granted May 9, 2023·2 cites·9 claims
- 4481US6830752B2Interferon-gamma-binding molecules for treating septic shock, cachexia, immune diseases and skin disordersINNOGENETICS NV·Filed 2002·Granted Dec 14, 2004·5 cites·18 claims
- 4580US2025257145A1ADAMTS Binding ImmunoglobulinsMERCK PATENT GMBH·Filed 2024·Application pending·0 cites
- 4679US12351630B2PD1 and/or LAG3 bindersMERCK SHARP & DOHME LLC·Filed 2021·Granted Jul 8, 2025·0 cites·7 claims
- 4779US11649290B2CTLA4 bindersMERCK SHARP & DOHME LLC·Filed 2019·Granted May 16, 2023·1 cites·14 claims
- 4876US6593079B1Method for simultaneous detection of HIV antigens and HIV antibodiesROCHE DIAGNOSTICS GMBH·Filed 1998·Granted Jul 15, 2003·31 cites·12 claims
- 4976US6521403B1Epitopes in viral envelope proteins and specific antibodies directed against these epitopes: use for detection of HCV viral antigen in host tissueINNOGENETICS NV·Filed 2000·Granted Feb 18, 2003·7 cites·8 claims
- 5073US11248055B2Polypeptides inhibiting CD40LABLYNX NV·Filed 2016·Granted Feb 15, 2022·2 cites·13 claims
Showing the top 50 of 88 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Marie-Ange Buyse files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →